Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups

In an effort to better understand the effects of venture capital investment on selected firm governance and financing structures, we examined the post-IPO experiences of 190 biotechnology and healthcare firms (see appendix). Our study revealed that in virtually all cases, the involvement of venture...

Full description

Saved in:
Bibliographic Details
Published in:Business horizons 2006-07, Vol.49 (4), p.303-311
Main Authors: Williams, David R., Duncan, W. Jack, Ginter, Peter M.
Format: Article
Language:English
Subjects:
Biotechnology industry
Corporate governance
Entrepreneurs
Health care industry
Impact analysis
Initial public offerings
Initial public offerings (IPOs)
Startups
Studies
Venture capital
Venture capitalists
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73
cites cdi_FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73
container_end_page 311
container_issue 4
container_start_page 303
container_title Business horizons
container_volume 49
creator Williams, David R.
Duncan, W. Jack
Ginter, Peter M.
description In an effort to better understand the effects of venture capital investment on selected firm governance and financing structures, we examined the post-IPO experiences of 190 biotechnology and healthcare firms (see appendix). Our study revealed that in virtually all cases, the involvement of venture capitalists reduced the role of the founder-entrepreneur in strategic decision making. This was illustrated by the larger proportion of outside directors when venture capitalists invested and the smaller proportion of entrepreneurs who remained officers or in board positions after the IPO. We also found that venture capitalists rarely invested alone, and preferred to structure deals in which venture capital partners share both risks and rewards.
doi_str_mv 10.1016/j.bushor.2005.11.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_195370583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0007681305001424</els_id><sourcerecordid>1048816961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73</originalsourceid><addsrcrecordid>eNp9kE9LxDAUxIMouK5-Aw_Be2te26SJB0GW9Q8IK6jnkKav2yxrW5N0wW9vl3r29BiYmcf8CLkGlgIDcbtLqzG0vU8zxngKkDIGJ2QBsswTwYQ8JQvGWJkICfk5uQhhd5QC8gXZv0c_2jh6121pjWYfqOlquu0P6DvTWaSmiehpbJG-vG3u6LqLHgePHY5-9h6wm_JIrRlcNHsXYqCuo63btjSibWmIxsdkHMIlOWumD3j1d5fk83H9sXpOXjdPL6uH18RmqoDEgiokh4rxhvPMSiNNWeRZVTIlJXKmGlUKLLkArCqslVCFKiqR1VywStgyX5KbuXfw_feIIepdP05z9kGD4nnJuMwnUzGbrO9D8Njowbsv4380MH3Eqnd6xqqPWDWAnrBOsfs5htOAg0Ovg3U4gaqdRxt13bv_C34BDkyDCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195370583</pqid></control><display><type>article</type><title>Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Williams, David R. ; Duncan, W. Jack ; Ginter, Peter M.</creator><creatorcontrib>Williams, David R. ; Duncan, W. Jack ; Ginter, Peter M.</creatorcontrib><description>In an effort to better understand the effects of venture capital investment on selected firm governance and financing structures, we examined the post-IPO experiences of 190 biotechnology and healthcare firms (see appendix). Our study revealed that in virtually all cases, the involvement of venture capitalists reduced the role of the founder-entrepreneur in strategic decision making. This was illustrated by the larger proportion of outside directors when venture capitalists invested and the smaller proportion of entrepreneurs who remained officers or in board positions after the IPO. We also found that venture capitalists rarely invested alone, and preferred to structure deals in which venture capital partners share both risks and rewards.</description><identifier>ISSN: 0007-6813</identifier><identifier>EISSN: 1873-6068</identifier><identifier>DOI: 10.1016/j.bushor.2005.11.001</identifier><identifier>CODEN: BHORAD</identifier><language>eng</language><publisher>Greenwich: Elsevier Inc</publisher><subject>Biotechnology industry ; Corporate governance ; Entrepreneurs ; Health care industry ; Impact analysis ; Initial public offerings ; Initial public offerings (IPOs) ; Startups ; Studies ; Venture capital ; Venture capitalists</subject><ispartof>Business horizons, 2006-07, Vol.49 (4), p.303-311</ispartof><rights>2005 Kelley School of Business, Indiana University</rights><rights>Copyright Elsevier Science Ltd. Jul/Aug 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73</citedby><cites>FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Williams, David R.</creatorcontrib><creatorcontrib>Duncan, W. Jack</creatorcontrib><creatorcontrib>Ginter, Peter M.</creatorcontrib><title>Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups</title><title>Business horizons</title><description>In an effort to better understand the effects of venture capital investment on selected firm governance and financing structures, we examined the post-IPO experiences of 190 biotechnology and healthcare firms (see appendix). Our study revealed that in virtually all cases, the involvement of venture capitalists reduced the role of the founder-entrepreneur in strategic decision making. This was illustrated by the larger proportion of outside directors when venture capitalists invested and the smaller proportion of entrepreneurs who remained officers or in board positions after the IPO. We also found that venture capitalists rarely invested alone, and preferred to structure deals in which venture capital partners share both risks and rewards.</description><subject>Biotechnology industry</subject><subject>Corporate governance</subject><subject>Entrepreneurs</subject><subject>Health care industry</subject><subject>Impact analysis</subject><subject>Initial public offerings</subject><subject>Initial public offerings (IPOs)</subject><subject>Startups</subject><subject>Studies</subject><subject>Venture capital</subject><subject>Venture capitalists</subject><issn>0007-6813</issn><issn>1873-6068</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LxDAUxIMouK5-Aw_Be2te26SJB0GW9Q8IK6jnkKav2yxrW5N0wW9vl3r29BiYmcf8CLkGlgIDcbtLqzG0vU8zxngKkDIGJ2QBsswTwYQ8JQvGWJkICfk5uQhhd5QC8gXZv0c_2jh6121pjWYfqOlquu0P6DvTWaSmiehpbJG-vG3u6LqLHgePHY5-9h6wm_JIrRlcNHsXYqCuo63btjSibWmIxsdkHMIlOWumD3j1d5fk83H9sXpOXjdPL6uH18RmqoDEgiokh4rxhvPMSiNNWeRZVTIlJXKmGlUKLLkArCqslVCFKiqR1VywStgyX5KbuXfw_feIIepdP05z9kGD4nnJuMwnUzGbrO9D8Njowbsv4380MH3Eqnd6xqqPWDWAnrBOsfs5htOAg0Ovg3U4gaqdRxt13bv_C34BDkyDCA</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Williams, David R.</creator><creator>Duncan, W. Jack</creator><creator>Ginter, Peter M.</creator><general>Elsevier Inc</general><general>Elsevier Science Ltd</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200607</creationdate><title>Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups</title><author>Williams, David R. ; Duncan, W. Jack ; Ginter, Peter M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biotechnology industry</topic><topic>Corporate governance</topic><topic>Entrepreneurs</topic><topic>Health care industry</topic><topic>Impact analysis</topic><topic>Initial public offerings</topic><topic>Initial public offerings (IPOs)</topic><topic>Startups</topic><topic>Studies</topic><topic>Venture capital</topic><topic>Venture capitalists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, David R.</creatorcontrib><creatorcontrib>Duncan, W. Jack</creatorcontrib><creatorcontrib>Ginter, Peter M.</creatorcontrib><collection>CrossRef</collection><jtitle>Business horizons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, David R.</au><au>Duncan, W. Jack</au><au>Ginter, Peter M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups</atitle><jtitle>Business horizons</jtitle><date>2006-07</date><risdate>2006</risdate><volume>49</volume><issue>4</issue><spage>303</spage><epage>311</epage><pages>303-311</pages><issn>0007-6813</issn><eissn>1873-6068</eissn><coden>BHORAD</coden><abstract>In an effort to better understand the effects of venture capital investment on selected firm governance and financing structures, we examined the post-IPO experiences of 190 biotechnology and healthcare firms (see appendix). Our study revealed that in virtually all cases, the involvement of venture capitalists reduced the role of the founder-entrepreneur in strategic decision making. This was illustrated by the larger proportion of outside directors when venture capitalists invested and the smaller proportion of entrepreneurs who remained officers or in board positions after the IPO. We also found that venture capitalists rarely invested alone, and preferred to structure deals in which venture capital partners share both risks and rewards.</abstract><cop>Greenwich</cop><pub>Elsevier Inc</pub><doi>10.1016/j.bushor.2005.11.001</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-6813
ispartof Business horizons, 2006-07, Vol.49 (4), p.303-311
issn 0007-6813
1873-6068
language eng
recordid cdi_proquest_journals_195370583
source ScienceDirect Freedom Collection 2022-2024
subjects Biotechnology industry
Corporate governance
Entrepreneurs
Health care industry
Impact analysis
Initial public offerings
Initial public offerings (IPOs)
Startups
Studies
Venture capital
Venture capitalists
title Structuring deals and governance after the IPO: Entrepreneurs and venture capitalists in high tech start-ups
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A30%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structuring%20deals%20and%20governance%20after%20the%20IPO:%20Entrepreneurs%20and%20venture%20capitalists%20in%20high%20tech%20start-ups&rft.jtitle=Business%20horizons&rft.au=Williams,%20David%20R.&rft.date=2006-07&rft.volume=49&rft.issue=4&rft.spage=303&rft.epage=311&rft.pages=303-311&rft.issn=0007-6813&rft.eissn=1873-6068&rft.coden=BHORAD&rft_id=info:doi/10.1016/j.bushor.2005.11.001&rft_dat=%3Cproquest_cross%3E1048816961%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2941-c194851b05f552c8a8a7432b70988e509f976e7561ebbed969494b62d560b6c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195370583&rft_id=info:pmid/&rfr_iscdi=true